AB

Alain D. Baron

ET Elcelyx Therapeutics: 13 patents #1 of 5Top 20%
AP Amylin Pharmaceuticals: 9 patents #17 of 151Top 15%
AL Astrazeneca Pharmaceuticals Lp: 6 patents #9 of 76Top 15%
AP Anji Pharmaceuticals: 2 patents #3 of 8Top 40%
SS Sidel Participations S.A.S: 1 patents #171 of 310Top 60%
📍 San Diego, CA: #1,129 of 23,606 inventorsTop 5%
🗺 California: #15,031 of 386,348 inventorsTop 4%
Overall (All Time): #106,545 of 4,157,543Top 3%
33
Patents All Time

Issued Patents All Time

Showing 1–25 of 33 patents

Patent #TitleCo-InventorsDate
11974971 Compositions and methods for treating metabolic disorders Mark S. Fineman, Nigel R. A. Beeley 2024-05-07
11759441 Biguanide compositions and methods of treating metabolic disorders Mark S. Fineman, Nigel R. A. Beeley 2023-09-19
11065215 Biguanide compositions and methods of treating metabolic disorders Mark S. Fineman, Nigel R. A. Beeley 2021-07-20
10668031 Biguanide compositions and methods of treating metabolic disorders Mark S. Fineman, Nigel R. A. Beeley 2020-06-02
10610500 Chemosensory receptor ligand-based therapies Nigel R. A. Beeley, Mark S. Fineman 2020-04-07
10603291 Compositions and methods for treating metabolic disorders Mark S. Fineman, Nigel R. A. Beeley 2020-03-31
10201511 Compositions and methods for treating metabolic disorders Mark S. Fineman, Nigel R. A. Beeley 2019-02-12
10159658 Compositions comprising statins, biguanides and further agents for reducing cardiometabolic risk Mark S. Fineman, Nigel R. A. Beeley 2018-12-25
10154972 Biguanide compositions and methods of treating metabolic disorders Mark S. Fineman, Nigel R. A. Beeley 2018-12-18
10028923 Biguanide compositions and methods of treating metabolic disorders Mark S. Fineman, Nigel R. A. Beeley 2018-07-24
9962344 Chemosensory receptor ligand-based therapies Nigel R. A. Beeley, Mark S. Fineman 2018-05-08
9901551 Chemosensory receptor ligand-based therapies Martin R. Brown, Christopher R. G. Jones 2018-02-27
9770422 Compositions and methods for treating metabolic disorders Mark S. Fineman, Nigel R. A. Beeley 2017-09-26
9572784 Compositions comprising statins, biguanides and further agents for reducing cardiometabolic risk Mark S. Fineman, Nigel R. A. Beeley 2017-02-21
9526741 Chemosensory receptor ligand-based therapies Martin R. Brown, Christopher R. G. Jones 2016-12-27
9486463 Chemosensory receptor ligand-based therapies Martin R. Brown, Christopher R. G. Jones, Mark S. Fineman 2016-11-08
9481642 Biguanide compositions and methods of treating metabolic disorders Mark S. Fineman, Nigel R. A. Beeley 2016-11-01
9480663 Biguanide compositions and methods of treating metabolic disorders Mark S. Fineman, Nigel R. A. Beeley 2016-11-01
9463170 Chemosensory receptor ligand-based therapies Nigel R. A. Beeley, Mark S. Fineman 2016-10-11
9211263 Compositions and methods of treating metabolic disorders Mark S. Fineman, Nigel R. A. Beeley 2015-12-15
9133260 GIP analog and hybrid polypeptides with selectable properties Odile Esther Levy, Lawrence J. D'Souza, Mary Erickson, Soumitra S. Ghosh, Michael R. Hanley +9 more 2015-09-15
9114560 Blowing device comprising a nozzle and a supply duct forming an obtuse angle Frederic Lecomte, Cedric Lemaire 2015-08-25
9050292 Chemosensory receptor ligand-based therapies Martin R. Brown, Christopher R. G. Jones, Nigel R. A. Beeley, Mark S. Fineman 2015-06-09
8895498 GIP and exendin hybrid polypeptides Odile Esther Levy, Lawrence J. D'Souza, Mary Erickson, Soumitra G. Ghosh, Michael R. Hanley +10 more 2014-11-25
8828953 Chemosensory receptor ligand-based therapies Martin R. Brown, Christopher R. G. Jones 2014-09-09